Metformin reverses development of pulmonary hypertension via aromatase inhibition

Article English OPEN
Dean, Afshan; Nilsen, Margaret; Loughlin, Lynn; Salt, Ian P.; MacLean, Margaret R.;
(2016)
  • Publisher: American Heart Association

Females are more susceptible to pulmonary arterial hypertension than males, although the reasons remain unclear. The hypoglycemic drug, metformin, is reported to have multiple actions, including the inhibition of aromatase and stimulation of AMP-activated protein kinase... View more
  • References (17)
    17 references, page 1 of 2

    1) McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O. Treatment goals of pulmonary hypertension. Journal of the American College of Cardiology. 2013;62:73-81.

    2) Mair KM, Johansen AK, Wright AF, Wallace E, MacLean MR. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. British Journal of Pharmacology. 2014;171:567-579.

    3) Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG,Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376-387.

    4) Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012;141:363-373.

    5) Tofovic SP. Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease. Journal of Cardiovascular Pharmacology. 2010;56:696-708.

    6) Paulin R, Michelakis ED. The estrogen puzzle in pulmonary arterial hypertension. Circulation. 2012;126:1016-1019.

    7) Wright AF, Ewart MA, Mair K, Nilsen M, Dempsie Y, Loughlin L, Maclean MR. Estrogen receptor alpha in pulmonary hypertension. Cardiovascular Research. 2015;106:206-216.

    8) Lahm T. Sex differences in pulmonary hypertension: are we cleaning up the mess? Eur Respir J 2016;47:390-393.

    9) Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. The American Journal of Physiology. 1981;240:62-72.

    10)Lahm T, Albrecht M, Fisher AJ, Selej M, Patel NG, Brown JA, Justice MJ, Brown MB, Van Demark M,Trulock KM, Dieudonne D, Reddy JG, Presson RG, Petrache I. 17beta-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. American Journal of Respiratory and Critical Care Medicine. 2012;185:965-980.

  • Metrics
Share - Bookmark